These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

789 related articles for article (PubMed ID: 28416760)

  • 21. KDM1A and KDM3A promote tumor growth by upregulating cell cycle-associated genes in pancreatic cancer.
    Hou X; Li Q; Yang L; Yang Z; He J; Li Q; Li D
    Exp Biol Med (Maywood); 2021 Sep; 246(17):1869-1883. PubMed ID: 34171978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. KDM3A-mediated demethylation of histone H3 lysine 9 facilitates the chromatin binding of Neurog2 during neurogenesis.
    Lin H; Zhu X; Chen G; Song L; Gao L; Khand AA; Chen Y; Lin G; Tao Q
    Development; 2017 Oct; 144(20):3674-3685. PubMed ID: 29042477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequencing the transcriptional network of androgen receptor in prostate cancer.
    Chng KR; Cheung E
    Cancer Lett; 2013 Nov; 340(2):254-60. PubMed ID: 23196061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lysine-specific demethylase KDM3A regulates ovarian cancer stemness and chemoresistance.
    Ramadoss S; Sen S; Ramachandran I; Roy S; Chaudhuri G; Farias-Eisner R
    Oncogene; 2017 Mar; 36(11):1537-1545. PubMed ID: 27694900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integration of regulatory networks by NKX3-1 promotes androgen-dependent prostate cancer survival.
    Tan PY; Chang CW; Chng KR; Wansa KD; Sung WK; Cheung E
    Mol Cell Biol; 2012 Jan; 32(2):399-414. PubMed ID: 22083957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamic change of chromatin conformation in response to hypoxia enhances the expression of GLUT3 (SLC2A3) by cooperative interaction of hypoxia-inducible factor 1 and KDM3A.
    Mimura I; Nangaku M; Kanki Y; Tsutsumi S; Inoue T; Kohro T; Yamamoto S; Fujita T; Shimamura T; Suehiro J; Taguchi A; Kobayashi M; Tanimura K; Inagaki T; Tanaka T; Hamakubo T; Sakai J; Aburatani H; Kodama T; Wada Y
    Mol Cell Biol; 2012 Aug; 32(15):3018-32. PubMed ID: 22645302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The histone H3K9 demethylase KDM3A promotes anoikis by transcriptionally activating pro-apoptotic genes BNIP3 and BNIP3L.
    Pedanou VE; Gobeil S; Tabariès S; Simone TM; Zhu LJ; Siegel PM; Green MR
    Elife; 2016 Jul; 5():. PubMed ID: 27472901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypoxia increases genome-wide bivalent epigenetic marking by specific gain of H3K27me3.
    Prickaerts P; Adriaens ME; Beucken TVD; Koch E; Dubois L; Dahlmans VEH; Gits C; Evelo CTA; Chan-Seng-Yue M; Wouters BG; Voncken JW
    Epigenetics Chromatin; 2016; 9():46. PubMed ID: 27800026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histone demethylase KDM7A controls androgen receptor activity and tumor growth in prostate cancer.
    Lee KH; Hong S; Kang M; Jeong CW; Ku JH; Kim HH; Kwak C
    Int J Cancer; 2018 Dec; 143(11):2849-2861. PubMed ID: 30183076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lgr4 promotes prostate tumorigenesis through the Jmjd2a/AR signaling pathway.
    Zhang J; Li Q; Zhang S; Xu Q; Wang T
    Exp Cell Res; 2016 Nov; 349(1):77-84. PubMed ID: 27743893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. c-MYC drives histone demethylase PHF8 during neuroendocrine differentiation and in castration-resistant prostate cancer.
    Maina PK; Shao P; Liu Q; Fazli L; Tyler S; Nasir M; Dong X; Qi HH
    Oncotarget; 2016 Nov; 7(46):75585-75602. PubMed ID: 27689328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A role for WDR5 in integrating threonine 11 phosphorylation to lysine 4 methylation on histone H3 during androgen signaling and in prostate cancer.
    Kim JY; Banerjee T; Vinckevicius A; Luo Q; Parker JB; Baker MR; Radhakrishnan I; Wei JJ; Barish GD; Chakravarti D
    Mol Cell; 2014 May; 54(4):613-25. PubMed ID: 24793694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The histone demethylase enzyme KDM3A is a key estrogen receptor regulator in breast cancer.
    Wade MA; Jones D; Wilson L; Stockley J; Coffey K; Robson CN; Gaughan L
    Nucleic Acids Res; 2015 Jan; 43(1):196-207. PubMed ID: 25488809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Independence of HIF1a and androgen signaling pathways in prostate cancer.
    Tran MGB; Bibby BAS; Yang L; Lo F; Warren AY; Shukla D; Osborne M; Hadfield J; Carroll T; Stark R; Scott H; Ramos-Montoya A; Massie C; Maxwell P; West CML; Mills IG; Neal DE
    BMC Cancer; 2020 May; 20(1):469. PubMed ID: 32450824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitamin C induces specific demethylation of H3K9me2 in mouse embryonic stem cells via Kdm3a/b.
    Ebata KT; Mesh K; Liu S; Bilenky M; Fekete A; Acker MG; Hirst M; Garcia BA; Ramalho-Santos M
    Epigenetics Chromatin; 2017; 10():36. PubMed ID: 28706564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor.
    Kang Z; Jänne OA; Palvimo JJ
    Mol Endocrinol; 2004 Nov; 18(11):2633-48. PubMed ID: 15308689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Context dependent regulatory patterns of the androgen receptor and androgen receptor target genes.
    Olsen JR; Azeem W; Hellem MR; Marvyin K; Hua Y; Qu Y; Li L; Lin B; Ke X; Øyan AM; Kalland K
    BMC Cancer; 2016 Jul; 16():377. PubMed ID: 27378372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extracellular vesicles-encapsulated let-7i shed from bone mesenchymal stem cells suppress lung cancer via KDM3A/DCLK1/FXYD3 axis.
    Liu J; Feng Y; Zeng X; He M; Gong Y; Liu Y
    J Cell Mol Med; 2021 Feb; 25(4):1911-1926. PubMed ID: 33350586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphorylation of histone H3T6 by PKCbeta(I) controls demethylation at histone H3K4.
    Metzger E; Imhof A; Patel D; Kahl P; Hoffmeyer K; Friedrichs N; Müller JM; Greschik H; Kirfel J; Ji S; Kunowska N; Beisenherz-Huss C; Günther T; Buettner R; Schüle R
    Nature; 2010 Apr; 464(7289):792-6. PubMed ID: 20228790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The KDM3A-KLF2-IRF4 axis maintains myeloma cell survival.
    Ohguchi H; Hideshima T; Bhasin MK; Gorgun GT; Santo L; Cea M; Samur MK; Mimura N; Suzuki R; Tai YT; Carrasco RD; Raje N; Richardson PG; Munshi NC; Harigae H; Sanda T; Sakai J; Anderson KC
    Nat Commun; 2016 Jan; 7():10258. PubMed ID: 26728187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.